However, a recent study on acute KRAS suppression in KRAS-mutant cells indicates that aberrant KRAS signaling drives cancer growth primarily through the MAPK-ERK pathway, influencing cell cycle progression at multiple levels including gene transcription and protein phosphorylation 8. This evidence concerns the gene KRAS and cancer.